`
`AO 120 (Rev. 08/10)
`
`Director of the U.S. Patent and Trademark Office
`
`Mail Stop 8
`TO:
`
`
`
`P.O. Box 1450
`
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`
`
`
`FILING OR DETERMINATION OF AN
`
`ACTION REGARDING A PATENT OR
`
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or IS U.S.C.
`
`
`
`has been § 1116 you are hereby advised that a court action
`
`
`
`
`filed in the U.S. District Court
`
`for the Northern District of West Virginia on the following
`
`
`
`
`
`
`D Trademarks or (M'Patents. ( D the patent action involves 35 U.S.C. § 292.):
`DOCKET NO.
`DATE FILED
`
`U.S. DISTRICT COURT
`
`for the Northern District of West Virginia
`PLAINTIFF
`DEFENDANT
`
`MYLAN PHARMACEUTICALS INC.
`NOVO NORDISK INC. and NOVO NORDISK NS
`PATENTOR
`DATE OF PATENT
`HOLDER OF PA TENT OR TRADEMARK
`TRADEMARK NO.
`OR TRADEMARK
`
`2/14/2012 Novo Nordisk A/S
`
`3/6/2012 Novo Nordisk NS
`9/17/2013 Novo Nordisk NS
`
`4/1/2014 Novo Nordisk A/S
`
`12/30/2014 Novo Nordisk A/S
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`
`
`
`DA TE INCLUDED INCLUDED
`BY D Amendment D Answer D Cross Bill D Other Pleading
`PATENTOR
`DATE OF PATENT
`HOLDER OF PATENT OR TRADEMARK
`TRADEMARK NO.
`OR TRADEMARK
`I
`3
`
`3/18/2022
`
`1 8,114,833
`
`2 8,129,343
`
`3 8,536,122
`
`4 8,684,969
`
`5 8,920,383
`
`2
`
`4
`
`s
`
`
`
`DECISION/JUDGEMENT
`
`
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`
`
`CHERYL DEAN RILEY
`
`I (BY) DEPUTY CLERK
`
`D. KINSEY
`
`3/18/2022
`
`Copy I-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`
`
`
`
`
`
`
`
`Copy 2-Upon fding document adding patcnt(s), mail this copy to Director Copy 4-Casc file copy
`
`
`
`Case 1:22-cv-00023-JPB Document 3 Filed 03/18/22 Page 2 of 2 PageID #: 455
`Case 1:22-cv-00023-JPB Document 3 Filed 03/18/22 Page 2 of 2 PagelD #: 455
`
`ADDENDUM TO AO 120 (ADDITIONAL PATENTS)
`
`DOCKET NO.
`
`PLAINTIFF
`
`DATE FILED
`3/18/2022
`
`U.S. DISTRICT COURT
`for the Northern District of West Virginia
`DEFENDANT
`
` NOVO NORDISKINC. and
`
`NOVO NORDISK A/S
`
`MYLAN PHARMACEUTICALS INC.
`
`
`
`
`
`r=[o,i08002|_-8/182015_[NovoNodskASSSCSCSC~“~*~*~S~SCS
`
`
`
`Nove Nordisk A/S
`
`Nove Nordisk A/S
`
`Novo Norsk A/S
`
`Novo Nordisk A/S
`
`Novo Nordisk A/S
`
`Novo Nordisk A/S
`
`Novo Nordisk A/S
`Novo Nordisk A/S
`Novo Nordisk A/S
`Novo Nordisk A/S
`Novo Nordisk A/S
`
`7/23/2019
`8/13/2019
`8/24/2021
`4/11/2017
`
`9,775,953
`
`10,357,616
`10,376,652
`11,097,063
`RE46,363
`
`
`
`71
`
`20
`
`
`
`
`
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`
`DATE INCLUDED
`
`PATENT OR
`
`INCLUDED BY
`[| Amendment
`DATE OF PATENT
`OR TRADEMARK.
`
`C] Answer
`
`C] Cross Bill
`
`CL Other Pleading
`
`HOLDEROF PATENT OR TRADEMARK
`
`